Opioid Receptor Agonist Market, Global Outlook and Forecast 2022-2028
Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
This report contains market size and forecasts of Opioid Receptor Agonist in global, including the following market information:
Global Opioid Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioid Receptor Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Opioid Receptor Agonist companies in 2021 (%)
The global Opioid Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fentanyl Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Receptor Agonist include Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Receptor Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioid Receptor Agonist Market Segment Percentages, by Type, 2021 (%)
Global Opioid Receptor Agonist Market Segment Percentages, by Application, 2021 (%)
Global Opioid Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Opioid Receptor Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioid Receptor Agonist revenues share in global market, 2021 (%)
Key companies Opioid Receptor Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Opioid Receptor Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Opioid Receptor Agonist in global, including the following market information:
Global Opioid Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioid Receptor Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Opioid Receptor Agonist companies in 2021 (%)
The global Opioid Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fentanyl Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Receptor Agonist include Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Receptor Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioid Receptor Agonist Market Segment Percentages, by Type, 2021 (%)
- Fentanyl
- Codeine
- Morphine
- Others
Global Opioid Receptor Agonist Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Opioid Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Opioid Receptor Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioid Receptor Agonist revenues share in global market, 2021 (%)
Key companies Opioid Receptor Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Opioid Receptor Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva Pharmaceutical Industries
- Johnson & Johnson
- Pfizer
- Fresenius Kabi
- Mylan N.V.
- Allergan
- US WorldMeds
- Piramal Critical Care
- DAIICHI SANKYO COMPANY
- Purdue Pharma
- Hikma Pharmaceuticals
- Endo Pharmaceuticals
- Sun Pharmaceutical Industries
- Tris Pharma
- Indivior
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Opioid Receptor Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Receptor Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OPIOID RECEPTOR AGONIST OVERALL MARKET SIZE
2.1 Global Opioid Receptor Agonist Market Size: 2021 VS 2028
2.2 Global Opioid Receptor Agonist Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Opioid Receptor Agonist Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Opioid Receptor Agonist Players in Global Market
3.2 Top Global Opioid Receptor Agonist Companies Ranked by Revenue
3.3 Global Opioid Receptor Agonist Revenue by Companies
3.4 Global Opioid Receptor Agonist Sales by Companies
3.5 Global Opioid Receptor Agonist Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Opioid Receptor Agonist Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Opioid Receptor Agonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Receptor Agonist Players in Global Market
3.8.1 List of Global Tier 1 Opioid Receptor Agonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Receptor Agonist Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Opioid Receptor Agonist Market Size Markets, 2021 & 2028
4.1.2 Fentanyl
4.1.3 Codeine
4.1.4 Morphine
4.1.5 Others
4.2 By Type - Global Opioid Receptor Agonist Revenue & Forecasts
4.2.1 By Type - Global Opioid Receptor Agonist Revenue, 2017-2022
4.2.2 By Type - Global Opioid Receptor Agonist Revenue, 2023-2028
4.2.3 By Type - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
4.3 By Type - Global Opioid Receptor Agonist Sales & Forecasts
4.3.1 By Type - Global Opioid Receptor Agonist Sales, 2017-2022
4.3.2 By Type - Global Opioid Receptor Agonist Sales, 2023-2028
4.3.3 By Type - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
4.4 By Type - Global Opioid Receptor Agonist Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Opioid Receptor Agonist Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application - Global Opioid Receptor Agonist Revenue & Forecasts
5.2.1 By Application - Global Opioid Receptor Agonist Revenue, 2017-2022
5.2.2 By Application - Global Opioid Receptor Agonist Revenue, 2023-2028
5.2.3 By Application - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
5.3 By Application - Global Opioid Receptor Agonist Sales & Forecasts
5.3.1 By Application - Global Opioid Receptor Agonist Sales, 2017-2022
5.3.2 By Application - Global Opioid Receptor Agonist Sales, 2023-2028
5.3.3 By Application - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
5.4 By Application - Global Opioid Receptor Agonist Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Opioid Receptor Agonist Market Size, 2021 & 2028
6.2 By Region - Global Opioid Receptor Agonist Revenue & Forecasts
6.2.1 By Region - Global Opioid Receptor Agonist Revenue, 2017-2022
6.2.2 By Region - Global Opioid Receptor Agonist Revenue, 2023-2028
6.2.3 By Region - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
6.3 By Region - Global Opioid Receptor Agonist Sales & Forecasts
6.3.1 By Region - Global Opioid Receptor Agonist Sales, 2017-2022
6.3.2 By Region - Global Opioid Receptor Agonist Sales, 2023-2028
6.3.3 By Region - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Opioid Receptor Agonist Revenue, 2017-2028
6.4.2 By Country - North America Opioid Receptor Agonist Sales, 2017-2028
6.4.3 US Opioid Receptor Agonist Market Size, 2017-2028
6.4.4 Canada Opioid Receptor Agonist Market Size, 2017-2028
6.4.5 Mexico Opioid Receptor Agonist Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Opioid Receptor Agonist Revenue, 2017-2028
6.5.2 By Country - Europe Opioid Receptor Agonist Sales, 2017-2028
6.5.3 Germany Opioid Receptor Agonist Market Size, 2017-2028
6.5.4 France Opioid Receptor Agonist Market Size, 2017-2028
6.5.5 U.K. Opioid Receptor Agonist Market Size, 2017-2028
6.5.6 Italy Opioid Receptor Agonist Market Size, 2017-2028
6.5.7 Russia Opioid Receptor Agonist Market Size, 2017-2028
6.5.8 Nordic Countries Opioid Receptor Agonist Market Size, 2017-2028
6.5.9 Benelux Opioid Receptor Agonist Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Opioid Receptor Agonist Revenue, 2017-2028
6.6.2 By Region - Asia Opioid Receptor Agonist Sales, 2017-2028
6.6.3 China Opioid Receptor Agonist Market Size, 2017-2028
6.6.4 Japan Opioid Receptor Agonist Market Size, 2017-2028
6.6.5 South Korea Opioid Receptor Agonist Market Size, 2017-2028
6.6.6 Southeast Asia Opioid Receptor Agonist Market Size, 2017-2028
6.6.7 India Opioid Receptor Agonist Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Opioid Receptor Agonist Revenue, 2017-2028
6.7.2 By Country - South America Opioid Receptor Agonist Sales, 2017-2028
6.7.3 Brazil Opioid Receptor Agonist Market Size, 2017-2028
6.7.4 Argentina Opioid Receptor Agonist Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Receptor Agonist Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Opioid Receptor Agonist Sales, 2017-2028
6.8.3 Turkey Opioid Receptor Agonist Market Size, 2017-2028
6.8.4 Israel Opioid Receptor Agonist Market Size, 2017-2028
6.8.5 Saudi Arabia Opioid Receptor Agonist Market Size, 2017-2028
6.8.6 UAE Opioid Receptor Agonist Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Corporate Summary
7.1.2 Teva Pharmaceutical Industries Business Overview
7.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Opioid Receptor Agonist Major Product Offerings
7.2.4 Johnson & Johnson Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Receptor Agonist Major Product Offerings
7.3.4 Pfizer Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Corporate Summary
7.4.2 Fresenius Kabi Business Overview
7.4.3 Fresenius Kabi Opioid Receptor Agonist Major Product Offerings
7.4.4 Fresenius Kabi Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.4.5 Fresenius Kabi Key News
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporate Summary
7.5.2 Mylan N.V. Business Overview
7.5.3 Mylan N.V. Opioid Receptor Agonist Major Product Offerings
7.5.4 Mylan N.V. Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.5.5 Mylan N.V. Key News
7.6 Allergan
7.6.1 Allergan Corporate Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Opioid Receptor Agonist Major Product Offerings
7.6.4 Allergan Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Key News
7.7 US WorldMeds
7.7.1 US WorldMeds Corporate Summary
7.7.2 US WorldMeds Business Overview
7.7.3 US WorldMeds Opioid Receptor Agonist Major Product Offerings
7.7.4 US WorldMeds Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.7.5 US WorldMeds Key News
7.8 Piramal Critical Care
7.8.1 Piramal Critical Care Corporate Summary
7.8.2 Piramal Critical Care Business Overview
7.8.3 Piramal Critical Care Opioid Receptor Agonist Major Product Offerings
7.8.4 Piramal Critical Care Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.8.5 Piramal Critical Care Key News
7.9 DAIICHI SANKYO COMPANY
7.9.1 DAIICHI SANKYO COMPANY Corporate Summary
7.9.2 DAIICHI SANKYO COMPANY Business Overview
7.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Major Product Offerings
7.9.4 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.9.5 DAIICHI SANKYO COMPANY Key News
7.10 Purdue Pharma
7.10.1 Purdue Pharma Corporate Summary
7.10.2 Purdue Pharma Business Overview
7.10.3 Purdue Pharma Opioid Receptor Agonist Major Product Offerings
7.10.4 Purdue Pharma Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.10.5 Purdue Pharma Key News
7.11 Hikma Pharmaceuticals
7.11.1 Hikma Pharmaceuticals Corporate Summary
7.11.2 Hikma Pharmaceuticals Opioid Receptor Agonist Business Overview
7.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Major Product Offerings
7.11.4 Hikma Pharmaceuticals Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.11.5 Hikma Pharmaceuticals Key News
7.12 Endo Pharmaceuticals
7.12.1 Endo Pharmaceuticals Corporate Summary
7.12.2 Endo Pharmaceuticals Opioid Receptor Agonist Business Overview
7.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Major Product Offerings
7.12.4 Endo Pharmaceuticals Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.12.5 Endo Pharmaceuticals Key News
7.13 Sun Pharmaceutical Industries
7.13.1 Sun Pharmaceutical Industries Corporate Summary
7.13.2 Sun Pharmaceutical Industries Opioid Receptor Agonist Business Overview
7.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Major Product Offerings
7.13.4 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.13.5 Sun Pharmaceutical Industries Key News
7.14 Tris Pharma
7.14.1 Tris Pharma Corporate Summary
7.14.2 Tris Pharma Business Overview
7.14.3 Tris Pharma Opioid Receptor Agonist Major Product Offerings
7.14.4 Tris Pharma Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.14.5 Tris Pharma Key News
7.15 Indivior
7.15.1 Indivior Corporate Summary
7.15.2 Indivior Business Overview
7.15.3 Indivior Opioid Receptor Agonist Major Product Offerings
7.15.4 Indivior Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.15.5 Indivior Key News
8 GLOBAL OPIOID RECEPTOR AGONIST PRODUCTION CAPACITY, ANALYSIS
8.1 Global Opioid Receptor Agonist Production Capacity, 2017-2028
8.2 Opioid Receptor Agonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Receptor Agonist Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 OPIOID RECEPTOR AGONIST SUPPLY CHAIN ANALYSIS
10.1 Opioid Receptor Agonist Industry Value Chain
10.2 Opioid Receptor Agonist Upstream Market
10.3 Opioid Receptor Agonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Receptor Agonist Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Opioid Receptor Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Receptor Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OPIOID RECEPTOR AGONIST OVERALL MARKET SIZE
2.1 Global Opioid Receptor Agonist Market Size: 2021 VS 2028
2.2 Global Opioid Receptor Agonist Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Opioid Receptor Agonist Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Opioid Receptor Agonist Players in Global Market
3.2 Top Global Opioid Receptor Agonist Companies Ranked by Revenue
3.3 Global Opioid Receptor Agonist Revenue by Companies
3.4 Global Opioid Receptor Agonist Sales by Companies
3.5 Global Opioid Receptor Agonist Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Opioid Receptor Agonist Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Opioid Receptor Agonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Receptor Agonist Players in Global Market
3.8.1 List of Global Tier 1 Opioid Receptor Agonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Receptor Agonist Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Opioid Receptor Agonist Market Size Markets, 2021 & 2028
4.1.2 Fentanyl
4.1.3 Codeine
4.1.4 Morphine
4.1.5 Others
4.2 By Type - Global Opioid Receptor Agonist Revenue & Forecasts
4.2.1 By Type - Global Opioid Receptor Agonist Revenue, 2017-2022
4.2.2 By Type - Global Opioid Receptor Agonist Revenue, 2023-2028
4.2.3 By Type - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
4.3 By Type - Global Opioid Receptor Agonist Sales & Forecasts
4.3.1 By Type - Global Opioid Receptor Agonist Sales, 2017-2022
4.3.2 By Type - Global Opioid Receptor Agonist Sales, 2023-2028
4.3.3 By Type - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
4.4 By Type - Global Opioid Receptor Agonist Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Opioid Receptor Agonist Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application - Global Opioid Receptor Agonist Revenue & Forecasts
5.2.1 By Application - Global Opioid Receptor Agonist Revenue, 2017-2022
5.2.2 By Application - Global Opioid Receptor Agonist Revenue, 2023-2028
5.2.3 By Application - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
5.3 By Application - Global Opioid Receptor Agonist Sales & Forecasts
5.3.1 By Application - Global Opioid Receptor Agonist Sales, 2017-2022
5.3.2 By Application - Global Opioid Receptor Agonist Sales, 2023-2028
5.3.3 By Application - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
5.4 By Application - Global Opioid Receptor Agonist Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Opioid Receptor Agonist Market Size, 2021 & 2028
6.2 By Region - Global Opioid Receptor Agonist Revenue & Forecasts
6.2.1 By Region - Global Opioid Receptor Agonist Revenue, 2017-2022
6.2.2 By Region - Global Opioid Receptor Agonist Revenue, 2023-2028
6.2.3 By Region - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
6.3 By Region - Global Opioid Receptor Agonist Sales & Forecasts
6.3.1 By Region - Global Opioid Receptor Agonist Sales, 2017-2022
6.3.2 By Region - Global Opioid Receptor Agonist Sales, 2023-2028
6.3.3 By Region - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Opioid Receptor Agonist Revenue, 2017-2028
6.4.2 By Country - North America Opioid Receptor Agonist Sales, 2017-2028
6.4.3 US Opioid Receptor Agonist Market Size, 2017-2028
6.4.4 Canada Opioid Receptor Agonist Market Size, 2017-2028
6.4.5 Mexico Opioid Receptor Agonist Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Opioid Receptor Agonist Revenue, 2017-2028
6.5.2 By Country - Europe Opioid Receptor Agonist Sales, 2017-2028
6.5.3 Germany Opioid Receptor Agonist Market Size, 2017-2028
6.5.4 France Opioid Receptor Agonist Market Size, 2017-2028
6.5.5 U.K. Opioid Receptor Agonist Market Size, 2017-2028
6.5.6 Italy Opioid Receptor Agonist Market Size, 2017-2028
6.5.7 Russia Opioid Receptor Agonist Market Size, 2017-2028
6.5.8 Nordic Countries Opioid Receptor Agonist Market Size, 2017-2028
6.5.9 Benelux Opioid Receptor Agonist Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Opioid Receptor Agonist Revenue, 2017-2028
6.6.2 By Region - Asia Opioid Receptor Agonist Sales, 2017-2028
6.6.3 China Opioid Receptor Agonist Market Size, 2017-2028
6.6.4 Japan Opioid Receptor Agonist Market Size, 2017-2028
6.6.5 South Korea Opioid Receptor Agonist Market Size, 2017-2028
6.6.6 Southeast Asia Opioid Receptor Agonist Market Size, 2017-2028
6.6.7 India Opioid Receptor Agonist Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Opioid Receptor Agonist Revenue, 2017-2028
6.7.2 By Country - South America Opioid Receptor Agonist Sales, 2017-2028
6.7.3 Brazil Opioid Receptor Agonist Market Size, 2017-2028
6.7.4 Argentina Opioid Receptor Agonist Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Receptor Agonist Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Opioid Receptor Agonist Sales, 2017-2028
6.8.3 Turkey Opioid Receptor Agonist Market Size, 2017-2028
6.8.4 Israel Opioid Receptor Agonist Market Size, 2017-2028
6.8.5 Saudi Arabia Opioid Receptor Agonist Market Size, 2017-2028
6.8.6 UAE Opioid Receptor Agonist Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Corporate Summary
7.1.2 Teva Pharmaceutical Industries Business Overview
7.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Opioid Receptor Agonist Major Product Offerings
7.2.4 Johnson & Johnson Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Receptor Agonist Major Product Offerings
7.3.4 Pfizer Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Corporate Summary
7.4.2 Fresenius Kabi Business Overview
7.4.3 Fresenius Kabi Opioid Receptor Agonist Major Product Offerings
7.4.4 Fresenius Kabi Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.4.5 Fresenius Kabi Key News
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporate Summary
7.5.2 Mylan N.V. Business Overview
7.5.3 Mylan N.V. Opioid Receptor Agonist Major Product Offerings
7.5.4 Mylan N.V. Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.5.5 Mylan N.V. Key News
7.6 Allergan
7.6.1 Allergan Corporate Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Opioid Receptor Agonist Major Product Offerings
7.6.4 Allergan Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Key News
7.7 US WorldMeds
7.7.1 US WorldMeds Corporate Summary
7.7.2 US WorldMeds Business Overview
7.7.3 US WorldMeds Opioid Receptor Agonist Major Product Offerings
7.7.4 US WorldMeds Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.7.5 US WorldMeds Key News
7.8 Piramal Critical Care
7.8.1 Piramal Critical Care Corporate Summary
7.8.2 Piramal Critical Care Business Overview
7.8.3 Piramal Critical Care Opioid Receptor Agonist Major Product Offerings
7.8.4 Piramal Critical Care Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.8.5 Piramal Critical Care Key News
7.9 DAIICHI SANKYO COMPANY
7.9.1 DAIICHI SANKYO COMPANY Corporate Summary
7.9.2 DAIICHI SANKYO COMPANY Business Overview
7.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Major Product Offerings
7.9.4 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.9.5 DAIICHI SANKYO COMPANY Key News
7.10 Purdue Pharma
7.10.1 Purdue Pharma Corporate Summary
7.10.2 Purdue Pharma Business Overview
7.10.3 Purdue Pharma Opioid Receptor Agonist Major Product Offerings
7.10.4 Purdue Pharma Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.10.5 Purdue Pharma Key News
7.11 Hikma Pharmaceuticals
7.11.1 Hikma Pharmaceuticals Corporate Summary
7.11.2 Hikma Pharmaceuticals Opioid Receptor Agonist Business Overview
7.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Major Product Offerings
7.11.4 Hikma Pharmaceuticals Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.11.5 Hikma Pharmaceuticals Key News
7.12 Endo Pharmaceuticals
7.12.1 Endo Pharmaceuticals Corporate Summary
7.12.2 Endo Pharmaceuticals Opioid Receptor Agonist Business Overview
7.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Major Product Offerings
7.12.4 Endo Pharmaceuticals Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.12.5 Endo Pharmaceuticals Key News
7.13 Sun Pharmaceutical Industries
7.13.1 Sun Pharmaceutical Industries Corporate Summary
7.13.2 Sun Pharmaceutical Industries Opioid Receptor Agonist Business Overview
7.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Major Product Offerings
7.13.4 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.13.5 Sun Pharmaceutical Industries Key News
7.14 Tris Pharma
7.14.1 Tris Pharma Corporate Summary
7.14.2 Tris Pharma Business Overview
7.14.3 Tris Pharma Opioid Receptor Agonist Major Product Offerings
7.14.4 Tris Pharma Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.14.5 Tris Pharma Key News
7.15 Indivior
7.15.1 Indivior Corporate Summary
7.15.2 Indivior Business Overview
7.15.3 Indivior Opioid Receptor Agonist Major Product Offerings
7.15.4 Indivior Opioid Receptor Agonist Sales and Revenue in Global (2017-2022)
7.15.5 Indivior Key News
8 GLOBAL OPIOID RECEPTOR AGONIST PRODUCTION CAPACITY, ANALYSIS
8.1 Global Opioid Receptor Agonist Production Capacity, 2017-2028
8.2 Opioid Receptor Agonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Receptor Agonist Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 OPIOID RECEPTOR AGONIST SUPPLY CHAIN ANALYSIS
10.1 Opioid Receptor Agonist Industry Value Chain
10.2 Opioid Receptor Agonist Upstream Market
10.3 Opioid Receptor Agonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Receptor Agonist Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Opioid Receptor Agonist in Global Market
Table 2. Top Opioid Receptor Agonist Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Opioid Receptor Agonist Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Opioid Receptor Agonist Revenue Share by Companies, 2017-2022
Table 5. Global Opioid Receptor Agonist Sales by Companies, (K Units), 2017-2022
Table 6. Global Opioid Receptor Agonist Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Opioid Receptor Agonist Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Opioid Receptor Agonist Product Type
Table 9. List of Global Tier 1 Opioid Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Opioid Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Opioid Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Opioid Receptor Agonist Sales (K Units), 2017-2022
Table 15. By Type - Global Opioid Receptor Agonist Sales (K Units), 2023-2028
Table 16. By Application – Global Opioid Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Opioid Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Opioid Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Opioid Receptor Agonist Sales (K Units), 2017-2022
Table 20. By Application - Global Opioid Receptor Agonist Sales (K Units), 2023-2028
Table 21. By Region – Global Opioid Receptor Agonist Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Opioid Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Opioid Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Opioid Receptor Agonist Sales (K Units), 2017-2022
Table 25. By Region - Global Opioid Receptor Agonist Sales (K Units), 2023-2028
Table 26. By Country - North America Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 29. By Country - North America Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 30. By Country - Europe Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 33. By Country - Europe Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 34. By Region - Asia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 37. By Region - Asia Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 38. By Country - South America Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 41. By Country - South America Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 46. Teva Pharmaceutical Industries Corporate Summary
Table 47. Teva Pharmaceutical Industries Opioid Receptor Agonist Product Offerings
Table 48. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Opioid Receptor Agonist Product Offerings
Table 51. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Opioid Receptor Agonist Product Offerings
Table 54. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Fresenius Kabi Corporate Summary
Table 56. Fresenius Kabi Opioid Receptor Agonist Product Offerings
Table 57. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Mylan N.V. Corporate Summary
Table 59. Mylan N.V. Opioid Receptor Agonist Product Offerings
Table 60. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Allergan Corporate Summary
Table 62. Allergan Opioid Receptor Agonist Product Offerings
Table 63. Allergan Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. US WorldMeds Corporate Summary
Table 65. US WorldMeds Opioid Receptor Agonist Product Offerings
Table 66. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Piramal Critical Care Corporate Summary
Table 68. Piramal Critical Care Opioid Receptor Agonist Product Offerings
Table 69. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. DAIICHI SANKYO COMPANY Corporate Summary
Table 71. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Offerings
Table 72. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Purdue Pharma Corporate Summary
Table 74. Purdue Pharma Opioid Receptor Agonist Product Offerings
Table 75. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Hikma Pharmaceuticals Corporate Summary
Table 77. Hikma Pharmaceuticals Opioid Receptor Agonist Product Offerings
Table 78. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Endo Pharmaceuticals Corporate Summary
Table 80. Endo Pharmaceuticals Opioid Receptor Agonist Product Offerings
Table 81. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Sun Pharmaceutical Industries Corporate Summary
Table 83. Sun Pharmaceutical Industries Opioid Receptor Agonist Product Offerings
Table 84. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Tris Pharma Corporate Summary
Table 86. Tris Pharma Opioid Receptor Agonist Product Offerings
Table 87. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Indivior Corporate Summary
Table 89. Indivior Opioid Receptor Agonist Product Offerings
Table 90. Indivior Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Opioid Receptor Agonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 92. Global Opioid Receptor Agonist Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Opioid Receptor Agonist Production by Region, 2017-2022 (K Units)
Table 94. Global Opioid Receptor Agonist Production by Region, 2023-2028 (K Units)
Table 95. Opioid Receptor Agonist Market Opportunities & Trends in Global Market
Table 96. Opioid Receptor Agonist Market Drivers in Global Market
Table 97. Opioid Receptor Agonist Market Restraints in Global Market
Table 98. Opioid Receptor Agonist Raw Materials
Table 99. Opioid Receptor Agonist Raw Materials Suppliers in Global Market
Table 100. Typical Opioid Receptor Agonist Downstream
Table 101. Opioid Receptor Agonist Downstream Clients in Global Market
Table 102. Opioid Receptor Agonist Distributors and Sales Agents in Global Market
Table 1. Key Players of Opioid Receptor Agonist in Global Market
Table 2. Top Opioid Receptor Agonist Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Opioid Receptor Agonist Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Opioid Receptor Agonist Revenue Share by Companies, 2017-2022
Table 5. Global Opioid Receptor Agonist Sales by Companies, (K Units), 2017-2022
Table 6. Global Opioid Receptor Agonist Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Opioid Receptor Agonist Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Opioid Receptor Agonist Product Type
Table 9. List of Global Tier 1 Opioid Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Opioid Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Opioid Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Opioid Receptor Agonist Sales (K Units), 2017-2022
Table 15. By Type - Global Opioid Receptor Agonist Sales (K Units), 2023-2028
Table 16. By Application – Global Opioid Receptor Agonist Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Opioid Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Opioid Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Opioid Receptor Agonist Sales (K Units), 2017-2022
Table 20. By Application - Global Opioid Receptor Agonist Sales (K Units), 2023-2028
Table 21. By Region – Global Opioid Receptor Agonist Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Opioid Receptor Agonist Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Opioid Receptor Agonist Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Opioid Receptor Agonist Sales (K Units), 2017-2022
Table 25. By Region - Global Opioid Receptor Agonist Sales (K Units), 2023-2028
Table 26. By Country - North America Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 29. By Country - North America Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 30. By Country - Europe Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 33. By Country - Europe Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 34. By Region - Asia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 37. By Region - Asia Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 38. By Country - South America Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 41. By Country - South America Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Opioid Receptor Agonist Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Opioid Receptor Agonist Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Opioid Receptor Agonist Sales, (K Units), 2023-2028
Table 46. Teva Pharmaceutical Industries Corporate Summary
Table 47. Teva Pharmaceutical Industries Opioid Receptor Agonist Product Offerings
Table 48. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Opioid Receptor Agonist Product Offerings
Table 51. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Opioid Receptor Agonist Product Offerings
Table 54. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Fresenius Kabi Corporate Summary
Table 56. Fresenius Kabi Opioid Receptor Agonist Product Offerings
Table 57. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Mylan N.V. Corporate Summary
Table 59. Mylan N.V. Opioid Receptor Agonist Product Offerings
Table 60. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Allergan Corporate Summary
Table 62. Allergan Opioid Receptor Agonist Product Offerings
Table 63. Allergan Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. US WorldMeds Corporate Summary
Table 65. US WorldMeds Opioid Receptor Agonist Product Offerings
Table 66. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Piramal Critical Care Corporate Summary
Table 68. Piramal Critical Care Opioid Receptor Agonist Product Offerings
Table 69. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. DAIICHI SANKYO COMPANY Corporate Summary
Table 71. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Offerings
Table 72. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Purdue Pharma Corporate Summary
Table 74. Purdue Pharma Opioid Receptor Agonist Product Offerings
Table 75. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Hikma Pharmaceuticals Corporate Summary
Table 77. Hikma Pharmaceuticals Opioid Receptor Agonist Product Offerings
Table 78. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Endo Pharmaceuticals Corporate Summary
Table 80. Endo Pharmaceuticals Opioid Receptor Agonist Product Offerings
Table 81. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Sun Pharmaceutical Industries Corporate Summary
Table 83. Sun Pharmaceutical Industries Opioid Receptor Agonist Product Offerings
Table 84. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Tris Pharma Corporate Summary
Table 86. Tris Pharma Opioid Receptor Agonist Product Offerings
Table 87. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Indivior Corporate Summary
Table 89. Indivior Opioid Receptor Agonist Product Offerings
Table 90. Indivior Opioid Receptor Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Opioid Receptor Agonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 92. Global Opioid Receptor Agonist Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Opioid Receptor Agonist Production by Region, 2017-2022 (K Units)
Table 94. Global Opioid Receptor Agonist Production by Region, 2023-2028 (K Units)
Table 95. Opioid Receptor Agonist Market Opportunities & Trends in Global Market
Table 96. Opioid Receptor Agonist Market Drivers in Global Market
Table 97. Opioid Receptor Agonist Market Restraints in Global Market
Table 98. Opioid Receptor Agonist Raw Materials
Table 99. Opioid Receptor Agonist Raw Materials Suppliers in Global Market
Table 100. Typical Opioid Receptor Agonist Downstream
Table 101. Opioid Receptor Agonist Downstream Clients in Global Market
Table 102. Opioid Receptor Agonist Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Opioid Receptor Agonist Segment by Type
Figure 2. Opioid Receptor Agonist Segment by Application
Figure 3. Global Opioid Receptor Agonist Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opioid Receptor Agonist Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Receptor Agonist Revenue, 2017-2028 (US$, Mn)
Figure 7. Opioid Receptor Agonist Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioid Receptor Agonist Revenue in 2021
Figure 9. By Type - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 10. By Type - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 11. By Type - Global Opioid Receptor Agonist Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 13. By Application - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 14. By Application - Global Opioid Receptor Agonist Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 16. By Region - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 17. By Country - North America Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 18. By Country - North America Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 19. US Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 24. Germany Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 25. France Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 33. China Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 37. India Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 39. By Country - South America Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 40. Brazil Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 44. Turkey Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 48. Global Opioid Receptor Agonist Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Opioid Receptor Agonist by Region, 2021 VS 2028
Figure 50. Opioid Receptor Agonist Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Opioid Receptor Agonist Segment by Type
Figure 2. Opioid Receptor Agonist Segment by Application
Figure 3. Global Opioid Receptor Agonist Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opioid Receptor Agonist Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Receptor Agonist Revenue, 2017-2028 (US$, Mn)
Figure 7. Opioid Receptor Agonist Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioid Receptor Agonist Revenue in 2021
Figure 9. By Type - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 10. By Type - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 11. By Type - Global Opioid Receptor Agonist Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 13. By Application - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 14. By Application - Global Opioid Receptor Agonist Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 16. By Region - Global Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 17. By Country - North America Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 18. By Country - North America Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 19. US Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 24. Germany Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 25. France Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 33. China Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 37. India Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 39. By Country - South America Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 40. Brazil Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Opioid Receptor Agonist Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Opioid Receptor Agonist Sales Market Share, 2017-2028
Figure 44. Turkey Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Opioid Receptor Agonist Revenue, (US$, Mn), 2017-2028
Figure 48. Global Opioid Receptor Agonist Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Opioid Receptor Agonist by Region, 2021 VS 2028
Figure 50. Opioid Receptor Agonist Industry Value Chain
Figure 51. Marketing Channels
